Prof Monica Morrow speaks to ecancer in an online interview for the virtual BGICC 2021 meeting about managing patients with HER2-positive breast cancer.
She speaks about the benefits of neo-adjuvant therapies for these patients, giving her practical advice for management strategies and discussing recent relevant research.
Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php
![](https://i.ytimg.com/vi/iHcHJ-30Bf0/maxresdefault.jpg)